Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ESBL, % (n = 203) | No ESBL, % (n = 137) | OR (CI 95%) | p | OR (CI 95%) | p | MRSA, % (n = 45) | No MRSA, % (n = 295) | OR (CI 95%) | p | OR (CI 95%) | p | |
Male sex | 34.9 | 31.3 | 1.17 (0.74–1.86) | 0.49 | 51.1 | 30.8 | 2.34 (1.24–4.42) | 0.008 | 2.31 (1.16–4.59) | 0.01 | ||
Age ≥ 86 years | 52.7 | 49.2 | 1.15 (0.74–1.78) | 0.53 | 39.0 | 53.0 | 0.56 (0.29–1.10) | 0.09 | ||||
Antibiotics in preceding 3 months | 39.9 | 23.3 | 2.17 (1.34–3.54) | 0.001 | 1.74 (1.02–2.98) | 0.04 | 37.7 | 32.5 | 1.25 (0.65–2.41) | 0.48 | ||
Fluoroquinolones | 7.8 | 5.8 | 1.38 (0.57–3.32) | 0.47 | 15.5 | 5.7 | 3.01 (1.17–7.73) | 0.02 | 3.59 (1.26–10.25) | 0.01 | ||
Penicillins | 7.3 | 2.9 | 2.65 (0.86–8.17) | 0.09 | 11.1 | 4.7 | 2.50 (0.85–7.34) | 0.09 | ||||
Cephalosporins | 14.2 | 6.5 | 2.37 (1.08–5.18) | 0.03 | 4.4 | 12.2 | 0.33 (0.07–1.44) | 0.14 | ||||
Dementia | 63.0 | 66.4 | 0.86 (0.54–1.36) | 0.52 | 62.2 | 64.7 | 0.89 (0.47–1.71) | 0.74 | ||||
Peripheral vascular disease | 62.5 | 59.1 | 1.15 (0.74–1.80) | 0.52 | 62.2 | 61.0 | 1.05 (0.55–2.00) | 0.87 | ||||
Urinary incontinence | 83.2 | 78.8 | 1.33 (0.77–2.31) | 0.30 | 82.2 | 81.3 | 1.06 (0.46–2.40) | 0.89 | ||||
Diabetes | 18.7 | 18.9 | 0.98 (0.56–1,71) | 0.30 | 26.6 | 17.6 | 1.69 (0.82–3.51) | 0.15 | ||||
Cancer | 11.8 | 4.3 | 2.92 (1.16–7.36) | 0.02 | 3.47 (1.32–9.16) | 0.01 | 4.4 | 9.5 | 0.44 (0.10–1.93) | 0.27 | ||
Decubitus ulcer | 9.8 | 5.1 | 2.03 (0.83–4.94) | 0.12 | 6.6 | 8.1 | 0.80 (0.23–2.79) | 0.73 | ||||
Chronic obstructive pulmonary disease | 11.8 | 14.6 | 0.78 (0.41–1.48) | 0.45 | 15.5 | 12.5 | 1.28 (0.53–3.08) | 0.57 | ||||
Physical disability (Barthel immobility score of 0) | 47.7 | 32.3 | 1.91 (1.21–3.02) | 0.005 | 2.10 (1.15–3.83) | 0.01 | 37.7 | 41.0 | 0.87 (0.45–1.66) | 0.67 | ||
Coma | 6.9 | 4.3 | 1.61 (0.60–4.31) | 0.33 | 6.6 | 5.7 | 1.16 (0.32–4.15) | 0.81 | ||||
Any medical device | 32.5 | 13.1 | 3.18 (1.79–5.66) | < 0.001 | 2.81 (1.44–5.47) | 0.002 | 33.3 | 23.3 | 1.63 (0.83–3.21) | 0.15 | ||
Percutaneous enteral gastrostomy tube | 15.7 | 6.5 | 2.66 (1.22–5.77) | 0.01 | 11.1 | 12.2 | 0.89 (0.33–2.42) | 0.83 | ||||
Tracheostomy tube | 4.9 | 2.1 | 2.31 (0.62–8.56) | 0.21 | 4.4 | 3.7 | 1.20 (0.25–5.60) | 0.81 | ||||
Urinary catheter | 15.7 | 4.3 | 4.08 (1.66–10.06) | 0.002 | 20.0 | 9.8 | 2.29 (1.00–5.23) | 0.04 | 2.61 (0.06–6.43) | 0.03 | ||
Nasogastric tube | 5.9 | 0.7 | 8.54 (1.09–66.49) | 0.04 | 4.4 | 3.7 | 1.20 (0.25–5.60) | 0.81 | ||||
Length of stay in LTCF < 6 months | 15.6 | 11.9 | 1.36 (0.71–2.61) | 0.34 | 16.6 | 13.7 | 1.25 (0.51–3.00) | 0.61 | ||||
Hospital admission in previous 12 months | 24.2 | 27.0 | 0.87 (0.53–1.43) | 0.58 | 37.7 | 23.4 | 1.97 (1.02–3.81) | 0.04 | ||||
Infection | 5.4 | 2.9 | 1.90 (0.59–6.11) | 0.27 | 8.8 | 3.7 | 2.51 (0.76–8.28) | 0.12 |